Bio-nanoparticle technology for sustainable pest control in agriculture
Biologically derived nanoparticles offer a sustainable approach to crop protection by enhancing fungicide efficacy and reducing environmental impact. These bionanoparticles improve adhesion and controlled release, aligning with sustainable agriculture trends.
Overview
Biologically derived nanoparticles, or bionanoparticles, present a revolutionary approach to sustainable pest control in agriculture. These nanoparticles are produced by microorganisms and exhibit antifungal and biostimulant activities, complementing conventional fungicides and biopesticides. By integrating with existing formulations, they enhance efficacy, reduce environmental impact, and align with sustainable agriculture trends. This technology offers a non-toxic solution that can improve crop protection while minimizing synthetic additive use.
Technical specifications
Bionanoparticles feature a unique biological coating that facilitates improved adhesion to plant surfaces, controlled release of active ingredients, and targeted action against pests. This reduces the need for additional synthetic additives and enhances the performance of existing agrochemical formulations. The nanoparticles are designed for compatibility with various application methods, including ultra-low volume (ULV) and drone-based delivery systems, optimizing their use in precision agriculture.
Technology readiness level
Currently at TRL 6, this technology is undergoing extensive validation. Initial formulation refinement will occur over six months to improve stability and efficacy. Large-scale field trials are planned to assess performance across diverse crops and conditions. Regulatory validation, including EPA registration, is targeted to ensure compliance. By transitioning from TRL 6, the technology is on a clear path towards commercialization and market readiness.
About CITES (Sancor Seguros)
CITES (Centro de Innovación Tecnológica, Empresarial y Social) is a venture capital firm and venture builder focused on the development of deep tech and scientific-technological startups. Founded in 2013 and initially backed by the Sancor Seguros Group, the organization invests in companies from the formation stage through Series A, providing both capital and operational support. CITES operates with a multidisciplinary team and utilizes specialized infrastructure, including wet labs, fab labs, and co-working spaces, to assist founders in transforming disruptive scientific research into global businesses. Their portfolio spans various sectors such as biotechnology, agtech, artificial intelligence, med-tech, and sustainable industrial technologies.
By serving as a bridge between laboratory innovation and commercial application, CITES addresses the challenges of early-stage scientific entrepreneurship in Latin America. The firm is recognized for its role in fostering the regional deep tech ecosystem through investment funds and incubation programs designed to bridge the development gap for researchers and scientists. Through strategic partnerships and a commitment to social, environmental, and economic progress, CITES helps startups scale their solutions while promoting an inclusive and diverse innovation environment. Their operational model emphasizes applied knowledge, with a proven track record of managing numerous patents and building a diverse portfolio of companies focused on addressing modern global challenges.
delivered to your inbox.